Join us at Discovery US and network with us and over 250 industry leaders. We will be there to discuss the latest advancements in ultra-High Throughput Screening, Mass Spectrometry, target identification, validation and HIT optimisation.
The 2-day programme addresses drug discovery in new modalities such as protein degradation, and case studies on the integration of screening approaches in phenotypic and genomics-based discovery, Organ-on-a-chip and 3D modelling
Click here for more information about the conference.
Our CSO, Saman Honarnejad, PhD, will be one of the speakers during this in-person event and will share with you his experience in the field of early drug discovery.
Be sure to join his session about Hit Profiler – An in-silico database & text mining tool for qualitative pharmacogenomic profiling of hit series & their corresponding chemical space on Wednesday November 1, 11:20 to 11:50 AM.
Want to meet our experts in person? Schedule your appointment with our experts here directly!
